GX EJ7
Generic Name: lamivudine
Pill imprint GX EJ7 has been identified as Epivir 300 mg.
Epivir is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.
Epivir 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Epivir Images
- Generic Name:
- lamivudine
- Imprint:
-
GX EJ7
- Strength:
- 300 mg
- Color:
- Gray
- Size:
- 17.00 mm
- Shape:
- Four-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- ferric oxide black
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0714
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5501 | A S Medication Solutions LLC (repackager) |
| 58016-0795 | Southwood Pharmaceuticals Inc (repackager) |
| 54868-5416 | Physicians Total Care Inc (repackager) |
| 35356-0065 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Epivir resources
Search Again
